Exploring genetic factors in childhood asthma
Official title: Association Between Cytokines Gene Single Nucleotide Polymorphisms and Type 2 Inflammatory Asthma in Children
Run by Guangzhou Institute of Respiratory Disease · NCT06840717 · Data updated 2026-11-12
This study is trying to see if certain genetic factors are linked to asthma in children to help find better treatments and prevention methods.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 14 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Guangzhou Institute of Respiratory Disease Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | January 30, 2024 |
| Main results expected | December 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT06840717 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children diagnosed with asthma who meet specific criteria for type 2 inflammation.
✕Probably not a fit
Patients with other respiratory diseases or those who have taken certain medications prior to the study may not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the association between genetic single nucleotide polymorphisms (SNPs) and type 2 inflammation-related asthma in children. It involves analyzing SNPs, lung function, and type 2 inflammation indicators in children diagnosed with asthma, comparing them to healthy controls. The goal is to identify genetic risk factors that may contribute to asthma and to provide insights for personalized treatment and prevention strategies.
Why it matters
Potential benefit: If successful, this study could lead to more tailored and effective treatments for children suffering from type 2 asthma.
How similar studies have gone: Other studies have shown promising results in understanding genetic factors in asthma, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All children with asthma diagnosis accord with the GINA in 2023 edition; 2. Other diseases that could cause wheezing and cough were excluded, such as acute laryngitis, diphtheria, congenital airway abnormalities, and tracheal foreign bodies; 3. In front of the hospital 2 weeks without antibiotics, systemic hormone medication history; 4. There were no other complications, such as congenital heart disease, pneumonia, gastroesophageal reflux disease, muscle dysplasia, etc. Exclusion Criteria: 1. Children who had taken immunosuppressants, antibiotics and other drugs for a long time before admission; 2. Children with primary immunodeficiency disease; 3. The children and their families failed to cooperate or refused the experimental observation.
Where it's running
-
Guangzhou institute of respiratory disease
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Lihong Sun, M.D.
- Email: sunlihong9797@126.com
- Phone: 13719240285
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
N-WATCH: Can a simple breath device help monitor asthma in kids
This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
ASMact: Managing bronchial asthma attacks in children
This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.
-
Newborn whole-genome sequencing and genetic disease risk in pregnancy and early life
This project will collect small biological samples from pregnant families and newborns to try whole-genome sequencing and other multi-omics tests to find genetic disease risks.
-
Biomarkers and Respiratory Omics in Children: Predicting Disease Course
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
-
Using technology and school–clinic coordination to improve asthma care for children.
This project will try a tech-enabled program plus school care coordination to help children ages 4–12 with persistent or uncontrolled asthma follow guideline-based treatment and have fewer symptoms and school problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.